Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectivenessnews2026-04-16T00:05:36+00:00April 16th, 2026|The New York Times|
GLP-1 Experimentation Is Everywhere, and Science Can’t Keep Upnews2026-04-15T21:43:41+00:00April 15th, 2026|The New York Times|
The New Alzheimer’s Blood Tests: What to Knownews2026-03-19T09:00:17+00:00March 19th, 2026|The New York Times|
Cuando los medicamentos para perder peso no funcionannews2026-03-15T05:00:10+00:00March 15th, 2026|The New York Times|
La mayoría de los pacientes mantendrían su peso con menos dosis de medicamentos GLP-1news2026-03-06T09:00:04+00:00March 6th, 2026|The New York Times|
Fewer Pregnant Women Received Acetaminophen in E.R.s After White House Warningsnews2026-03-05T23:31:25+00:00March 5th, 2026|The New York Times|
F.D.A. Faces Upset Over Denials of New Drugsnews2026-03-05T19:26:40+00:00March 5th, 2026|The New York Times|
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Findsnews2026-03-04T20:53:59+00:00March 4th, 2026|The New York Times|
La ostarina, el fármaco que está en el centro del dopaje deportivonews2026-02-03T10:04:43+00:00February 3rd, 2026|The New York Times|
